These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 11087710

  • 1. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2.
    Pye DA, Vivès RR, Hyde P, Gallagher JT.
    Glycobiology; 2000 Nov; 10(11):1183-92. PubMed ID: 11087710
    [Abstract] [Full Text] [Related]

  • 2. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity.
    Pye DA, Vives RR, Turnbull JE, Hyde P, Gallagher JT.
    J Biol Chem; 1998 Sep 04; 273(36):22936-42. PubMed ID: 9722514
    [Abstract] [Full Text] [Related]

  • 3. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.
    Ornitz DM, Herr AB, Nilsson M, Westman J, Svahn CM, Waksman G.
    Science; 1995 Apr 21; 268(5209):432-6. PubMed ID: 7536345
    [Abstract] [Full Text] [Related]

  • 4. Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate.
    Ashikari-Hada S, Habuchi H, Sugaya N, Kobayashi T, Kimata K.
    Glycobiology; 2009 Jun 21; 19(6):644-54. PubMed ID: 19254961
    [Abstract] [Full Text] [Related]

  • 5. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells.
    Jayson GC, Gallagher JT.
    Br J Cancer; 1997 Jun 21; 75(1):9-16. PubMed ID: 9000592
    [Abstract] [Full Text] [Related]

  • 6. Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity.
    Taylor KR, Rudisill JA, Gallo RL.
    J Biol Chem; 2005 Feb 18; 280(7):5300-6. PubMed ID: 15563459
    [Abstract] [Full Text] [Related]

  • 7. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A, Guimond S, Rapraeger AC.
    Biochemistry; 1996 Aug 27; 35(34):11131-41. PubMed ID: 8780517
    [Abstract] [Full Text] [Related]

  • 8. Structural comparison of fibroblast growth factor-specific heparan sulfates derived from a growing or differentiating neuroepithelial cell line.
    Brickman YG, Nurcombe V, Ford MD, Gallagher JT, Bartlett PF, Turnbull JE.
    Glycobiology; 1998 May 27; 8(5):463-71. PubMed ID: 9597544
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
    Ostrovsky O, Berman B, Gallagher J, Mulloy B, Fernig DG, Delehedde M, Ron D.
    J Biol Chem; 2002 Jan 25; 277(4):2444-53. PubMed ID: 11714710
    [Abstract] [Full Text] [Related]

  • 10. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.
    Ishihara M.
    Glycobiology; 1994 Dec 25; 4(6):817-24. PubMed ID: 7537556
    [Abstract] [Full Text] [Related]

  • 11. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
    Fromm JR, Hileman RE, Weiler JM, Linhardt RJ.
    Arch Biochem Biophys; 1997 Oct 15; 346(2):252-62. PubMed ID: 9343372
    [Abstract] [Full Text] [Related]

  • 12. In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity.
    Guillonneau X, Tassin J, Berrou E, Bryckaert M, Courtois Y, Mascarelli F.
    J Cell Physiol; 1996 Jan 15; 166(1):170-87. PubMed ID: 8557766
    [Abstract] [Full Text] [Related]

  • 13. Comparable stabilisation, structural changes and activities can be induced in FGF by a variety of HS and non-GAG analogues: implications for sequence-activity relationships.
    Rudd TR, Uniewicz KA, Ori A, Guimond SE, Skidmore MA, Gaudesi D, Xu R, Turnbull JE, Guerrini M, Torri G, Siligardi G, Wilkinson MC, Fernig DG, Yates EA.
    Org Biomol Chem; 2010 Dec 07; 8(23):5390-7. PubMed ID: 20865198
    [Abstract] [Full Text] [Related]

  • 14. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
    Ashikari-Hada S, Habuchi H, Kariya Y, Itoh N, Reddi AH, Kimata K.
    J Biol Chem; 2004 Mar 26; 279(13):12346-54. PubMed ID: 14707131
    [Abstract] [Full Text] [Related]

  • 15. Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.
    Zhang F, Zhang Z, Lin X, Beenken A, Eliseenkova AV, Mohammadi M, Linhardt RJ.
    Biochemistry; 2009 Sep 08; 48(35):8379-86. PubMed ID: 19591432
    [Abstract] [Full Text] [Related]

  • 16. 6-O-sulfation of heparan sulfate differentially regulates various fibroblast growth factor-dependent signalings in culture.
    Sugaya N, Habuchi H, Nagai N, Ashikari-Hada S, Kimata K.
    J Biol Chem; 2008 Apr 18; 283(16):10366-76. PubMed ID: 18281280
    [Abstract] [Full Text] [Related]

  • 17. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
    Loo BM, Kreuger J, Jalkanen M, Lindahl U, Salmivirta M.
    J Biol Chem; 2001 May 18; 276(20):16868-76. PubMed ID: 11278860
    [Abstract] [Full Text] [Related]

  • 18. Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis.
    Cole CL, Hansen SU, Baráth M, Rushton G, Gardiner JM, Avizienyte E, Jayson GC.
    PLoS One; 2010 Jul 21; 5(7):e11644. PubMed ID: 20657775
    [Abstract] [Full Text] [Related]

  • 19. Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors.
    Jastrebova N, Vanwildemeersch M, Rapraeger AC, Giménez-Gallego G, Lindahl U, Spillmann D.
    J Biol Chem; 2006 Sep 15; 281(37):26884-92. PubMed ID: 16807244
    [Abstract] [Full Text] [Related]

  • 20. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
    Delehedde M, Deudon E, Boilly B, Hondermarck H.
    Exp Cell Res; 1996 Dec 15; 229(2):398-406. PubMed ID: 8986623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.